Description
Access Bio CareStart™ COVID-19 Rapid POC Antigen Test 20 Kits/Box
RAPID POC TEST
Due to the highly contagious nature and global health crisis, SARS-CoV-2 has been designated as a pandemic by the World Health Organization (WHO) and continues to have devastating impacts on healthcare systems and the world economy including the U.S. To effectively end the SARS-CoV-2 pandemic, systematic screening and detection of both clinical and asymptomatic COVID-19 cases is critical.
As an intended point-of-care (POC) designated test performed by medical professionals with a 10 minutes processing time, CareStart™ COVID-19 Antigen Test helps provide critical answers about active infections to patients and healthcare workers alike.
- Lateral flow assay
- Rapid results in 10 minutes
- Nasopharyngeal swab specimen collection
- Intended at POC setting (i.e., in patient care settings) by medical professionals operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation
- Detect SARS-CoV-2 nucleocapsid protein antigen
TEST PRINCIPLES
The CareStart™ COVID-19 Antigen Test is a lateral flow immunochromatographic assay for the detection of extracted nucleocapsid protein antigens specific to SARS-CoV-2 in swab specimens directly collected from symptomatic individuals who are suspected of COVID-19 by their healthcare providers.
TEST PROCEDURE
![]() |
![]() |
![]() |
![]() |
---|---|---|---|
![]() |
![]() |
![]() |
![]() |
RESULTS INTERPRETATION
Covid-19 Positive | Covid-19 Negative | Invalid |
---|---|---|
|
|
|
PRODUCT DOCUMENTATION (DOWNLOAD & PRINT)
ORDERINGINFORMATION | |
CAT. NO. | RCHM-02071 |
KIT QUANTITY | 20 TESTS / KIT |
KIT COMPONENTS | 20 TEST DEVICES 20 ASSAY BUFFER 20 EXTRACTION VIALS AND CAPS 20 SPECIMEN COLLECTION SWABS 1 POSITIVE AND 1 NEGATIVE CONTROL SWABS 1 INSTRUCTIONS FOR USE |